vaccines

The feds placed a $2 billion order for 100 million doses of Pfizer’s potential coronavirus vaccine under the Trump administration’s push to have a shot ready by next year. Americans would receive Pfizer’s shots for free under the deal announced Wednesday — assuming the vaccine it’s developing with the German biotech firm BioNTech wins federal …

An early human trial of Oxford University’s experimental coronavirus vaccine has yielded a strong immune response in hundreds of people, according to newly released data. The potential vaccine, which the U.K. university developed in partnership with drugmaker AstraZeneca, was administered in a trial that involved 1,077 people and caused an immune response in people aged …

Biotech company Moderna announced on Tuesday that a potential coronavirus vaccine has produced a “robust” immune response in all patients participating in early vaccine trials. The trials centered on three groups of 45 patients, each of whom received the trial vaccine. While preliminary data from the trials was released in May, those results have now …

Prince William ventured out to visit an Oxford University coronavirus vaccine lab – becoming the first British royal to be seen wearing a face mask amid the pandemic, according to a report. Wearing a mask and googles, the Duke of Cambridge met “guinea pigs” testing the vaccine on Wednesday and told researchers that their work …

Dr. Anthony Fauci, chief medical advisor for the Trump administration’s coronavirus task force, said Tuesday that he is “cautiously optimistic” that a vaccine for the coronavirus will be available to the American public by the end of the year or early 2021. “The hallmark of all really defining responses that we have to virus diseases, …

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in a handful of deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower-income countries. The deals with epidemic response group CEPI and vaccine alliance GAVI are backed by the World Health Organization and aim to quell …

Swiss drugmaker Novartis will start producing a genetic coronavirus vaccine this month under a deal with Massachusetts researchers. AveXis, Novartis’s gene-therapy arm, agreed to manufacture the vaccine being developed by Massachusetts Eye and Ear and Massachusetts General Hospital. Production will start in time for clinical trials that are scheduled to begin in the second half …

The chief executive of AstraZeneca, which is developing a leading coronavirus vaccine with Oxford University, said it is too early to deliberately expose trial participants to the pathogen, but it may become an option if ongoing tests hit a snag. The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking …

The feds have ordered 300 million doses of a potential coronavirus vaccine from British drugmaker AstraZeneca, officials said Thursday. The company will get up to $1.2 billion from the US Department of Health and Human Services to speed the development and production of the vaccine with the goal of delivering the first doses as early …

US stocks slid Tuesday as investors reined in their optimism about a promising coronavirus vaccine. The Dow Jones industrial average dipped as much as 135.71 points, or 0.5 percent, to 24,461.66 in early trading to give back some its 900-point Monday rally. Hardware store chain Home Depot led the blue-chip index lower with its shares …